We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
Cap. Flow
+$1.17B
Cap. Flow %
9.66%
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$197M
2
BABA icon
Alibaba
BABA
+$190M
3
AMZN icon
Amazon
AMZN
+$161M
4
GDDY icon
GoDaddy
GDDY
+$135M
5
DIS icon
Walt Disney
DIS
+$132M

Sector Composition

Rank Sector Weight
1 Healthcare 24.88%
2 Consumer Discretionary 23.99%
3 Technology 11.1%
4 Financials 8.14%
5 Industrials 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTCH icon
726
Match Group
MTCH
$9.21B
$2.35M 0.02%
34,916
-66,454
-66% -$4.35M
INCY icon
727
Incyte
INCY
$25.4B
$2.34M 0.02%
27,579
+11,316
+70% +$908K
FE icon
728
FirstEnergy
FE
$28.9B
$2.34M 0.02%
54,622
-25,941
-32% -$1.09M
AXTA icon
729
Axalta
AXTA
$7.63B
$2.33M 0.02%
78,437
-218,942
-74% -$5.8M
BCC icon
730
Boise Cascade
BCC
$2.86B
$2.32M 0.02%
+82,604
New +$2.14M
CUB
731
DELISTED
Cubic Corporation
CUB
$2.31M 0.02%
35,779
+27,248
+319% +$1.6M
CNR
732
DELISTED
Cornerstone Building Brands, Inc.
CNR
$2.3M 0.02%
394,692
-793,008
-67% -$4.41M
WHF icon
733
WhiteHorse Finance
WHF
$143M
$2.3M 0.02%
166,991
+79,600
+91% +$1.13M
BTG icon
734
B2Gold
BTG
$5.17B
$2.29M 0.02%
+753,465
New +$2.06M
FMS icon
735
Fresenius Medical Care
FMS
$13.3B
$2.28M 0.02%
58,069
-101,573
-64% -$4.02M
AGNC icon
736
AGNC Investment
AGNC
$12.7B
$2.26M 0.02%
+134,276
New +$2.33M
VVX icon
737
V2X
VVX
$2.83B
$2.25M 0.02%
55,478
-93,741
-63% -$3.44M
RYN icon
738
Rayonier
RYN
$6.66B
$2.24M 0.02%
+81,510
New +$2.28M
PAGP icon
739
Plains GP Holdings
PAGP
$5.17B
$2.23M 0.02%
+89,120
New +$2.15M
FFBC icon
740
First Financial Bancorp
FFBC
$3.53B
$2.22M 0.02%
+91,474
New +$2.2M
GRA
741
DELISTED
W.R. Grace & Co.
GRA
$2.21M 0.02%
+28,998
New +$2.17M
COHR icon
742
Coherent
COHR
$46.5B
$2.2M 0.02%
60,200
-6,278
-9% -$229K
HSTM icon
743
HealthStream
HSTM
$834M
$2.18M 0.02%
84,133
+11,796
+16% +$310K
CBZ icon
744
CBIZ
CBZ
$2.5B
$2.17M 0.02%
110,896
+8,780
+9% +$176K
ASHR icon
745
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.53B
$2.17M 0.02%
77,031
+60,169
+357% +$1.68M
TAST
746
DELISTED
Carrols Restaurant Group, Inc.
TAST
$2.17M 0.02%
239,766
-83,687
-26% -$768K
KWEB icon
747
KraneShares CSI China Internet ETF
KWEB
$5.4B
$2.16M 0.02%
49,233
+46,269
+1,561% +$2.08M
LAUR icon
748
Laureate Education
LAUR
$5.27B
$2.16M 0.02%
+137,691
New +$2.19M
BTU icon
749
Peabody Energy
BTU
$2.79B
$2.16M 0.02%
+89,504
New +$2.35M
OI icon
750
O-I Glass
OI
$1.46B
$2.15M 0.02%
124,733
+124,714
+656,389% +$2.22M

Similar funds

Marshall Wace's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.

  • Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
  • Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
  • Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
  • Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
  • Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
  • Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.

Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.